Cargando…

Use of Bayesian methods to model the SF-6D health state preference based data

BACKGROUND: Conventionally, models used for health state valuation data have been frequentists. Recently a number of researchers have investigated the use of Bayesian methods in this area. The aim of this paper is to put on the map of modelling a new approach to estimating SF-6D health state utility...

Descripción completa

Detalles Bibliográficos
Autor principal: Kharroubi, Samer A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299638/
https://www.ncbi.nlm.nih.gov/pubmed/30563528
http://dx.doi.org/10.1186/s12955-018-1068-7
_version_ 1783381528547426304
author Kharroubi, Samer A.
author_facet Kharroubi, Samer A.
author_sort Kharroubi, Samer A.
collection PubMed
description BACKGROUND: Conventionally, models used for health state valuation data have been frequentists. Recently a number of researchers have investigated the use of Bayesian methods in this area. The aim of this paper is to put on the map of modelling a new approach to estimating SF-6D health state utility values using Bayesian methods. This will help health care professionals in deriving better health state utilities of the original UK SF-6D for their specialized applications. METHODS: The valuation study is composed of 249 SF-6D health states valued by a representative sample of the UK population using the standard gamble technique. Throughout this paper, we present four different models, including one simple linear regression model and three random effect models. The predictive ability of these models is assessed by comparing predicted and observed mean SF-6D scores, R(2)/adjusted R(2) and RMSE. All analyses were carried out using Bayesian Markov chain Monte Carlo (MCMC) simulation methods freely available in the specialist software WinBUGS. RESULTS: The random effects model with interaction model performs best under all criterions, with mean predicted error of 0.166, R(2)/adjusted R(2) of 0.683 and RMSE of 0.218. CONCLUSIONS: The Bayesian models provide flexible approaches to estimate mean SF-6D utility estimates, including characterizing the full range of uncertainty inherent in these estimates. We hope that this work will provide applied researchers with a practical set of tools to appropriately model outcomes in cost-effectiveness analysis.
format Online
Article
Text
id pubmed-6299638
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-62996382018-12-20 Use of Bayesian methods to model the SF-6D health state preference based data Kharroubi, Samer A. Health Qual Life Outcomes Research BACKGROUND: Conventionally, models used for health state valuation data have been frequentists. Recently a number of researchers have investigated the use of Bayesian methods in this area. The aim of this paper is to put on the map of modelling a new approach to estimating SF-6D health state utility values using Bayesian methods. This will help health care professionals in deriving better health state utilities of the original UK SF-6D for their specialized applications. METHODS: The valuation study is composed of 249 SF-6D health states valued by a representative sample of the UK population using the standard gamble technique. Throughout this paper, we present four different models, including one simple linear regression model and three random effect models. The predictive ability of these models is assessed by comparing predicted and observed mean SF-6D scores, R(2)/adjusted R(2) and RMSE. All analyses were carried out using Bayesian Markov chain Monte Carlo (MCMC) simulation methods freely available in the specialist software WinBUGS. RESULTS: The random effects model with interaction model performs best under all criterions, with mean predicted error of 0.166, R(2)/adjusted R(2) of 0.683 and RMSE of 0.218. CONCLUSIONS: The Bayesian models provide flexible approaches to estimate mean SF-6D utility estimates, including characterizing the full range of uncertainty inherent in these estimates. We hope that this work will provide applied researchers with a practical set of tools to appropriately model outcomes in cost-effectiveness analysis. BioMed Central 2018-12-18 /pmc/articles/PMC6299638/ /pubmed/30563528 http://dx.doi.org/10.1186/s12955-018-1068-7 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Kharroubi, Samer A.
Use of Bayesian methods to model the SF-6D health state preference based data
title Use of Bayesian methods to model the SF-6D health state preference based data
title_full Use of Bayesian methods to model the SF-6D health state preference based data
title_fullStr Use of Bayesian methods to model the SF-6D health state preference based data
title_full_unstemmed Use of Bayesian methods to model the SF-6D health state preference based data
title_short Use of Bayesian methods to model the SF-6D health state preference based data
title_sort use of bayesian methods to model the sf-6d health state preference based data
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299638/
https://www.ncbi.nlm.nih.gov/pubmed/30563528
http://dx.doi.org/10.1186/s12955-018-1068-7
work_keys_str_mv AT kharroubisamera useofbayesianmethodstomodelthesf6dhealthstatepreferencebaseddata